Active Ingredient: LINAGLIPTIN
Proprietary Name: TRADJENTA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N201280
Product Number: 001
Approval Date: May 2, 2011
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information